Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025

This bill aims to help people get uterine fibroids found and treated sooner. It tells the U.S. health department to study better ways to spot fibroids early and to create proven or promising steps that clinics can use, finished as quickly as possible and shared with programs that get grant money.

It also lets the department give grants to states to run programs that boost early detection and treatment and to launch public education campaigns. Grant funds can pay for screenings (including advanced imaging), patient navigation, putting proven steps into practice in clinics, and helping people reach care. States that plan to serve areas with socially vulnerable groups at higher risk will be put first in line for these grants. The bill also funds research, including possible clinical trials, on unequal pain control during fibroid surgeries and on conditions like Asherman’s syndrome and other uterine adhesions. The department must publish public reports every two years on what the grants and research are finding.

• Who is affected: People with or at risk for uterine fibroids, especially in high‑risk, socially vulnerable communities; state health agencies; clinics and hospitals.
• What changes: New state grants for screenings, patient support, and public awareness; new research on pain care and related uterine conditions; regular public updates on progress.
• When: Clinic steps must be finished and shared quickly; public reports are due every two years after grants begin and after the law takes effect.